Free Trial

Pluri (PLUR) Stock Price, News & Analysis

Pluri logo
$4.95 -0.46 (-8.50%)
Closing price 03:34 PM Eastern
Extended Trading
$4.66 -0.29 (-5.86%)
As of 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Pluri Stock (NASDAQ:PLUR)

Key Stats

Today's Range
$5.02
$5.31
50-Day Range
$3.96
$5.79
52-Week Range
$3.33
$7.13
Volume
6,705 shs
Average Volume
20,793 shs
Market Capitalization
$38.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Buy

Company Overview

Pluri Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
71st Percentile Overall Score

PLUR MarketRank™: 

Pluri scored higher than 71% of companies evaluated by MarketBeat, and ranked 302nd out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pluri has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Pluri has only been the subject of 1 research reports in the past 90 days.

  • Read more about Pluri's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pluri is -0.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pluri is -0.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Pluri has a P/B Ratio of 4.95. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Pluri's valuation and earnings.
  • Percentage of Shares Shorted

    0.70% of the float of Pluri has been sold short.
  • Short Interest Ratio / Days to Cover

    Pluri has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pluri has recently decreased by 12.88%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Pluri does not currently pay a dividend.

  • Dividend Growth

    Pluri does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.70% of the float of Pluri has been sold short.
  • Short Interest Ratio / Days to Cover

    Pluri has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pluri has recently decreased by 12.88%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Pluri has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.96 average news sentiment score of Medical companies.
  • Search Interest

    Only 1 people have searched for PLUR on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Pluri to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pluri insiders have bought more of their company's stock than they have sold. Specifically, they have bought $4,500,001.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    25.93% of the stock of Pluri is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 16.59% of the stock of Pluri is held by institutions.

  • Read more about Pluri's insider trading history.
Receive PLUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pluri and its competitors with MarketBeat's FREE daily newsletter.

PLUR Stock News Headlines

Pluri (NASDAQ:PLUR) Trading Down 4% - Should You Sell?
Miss This Window And You Miss Everything
There’s a moment in every crypto cycle when everything just clicks — and that moment is now. This is the phase when momentum builds, news turns bullish, and markets ignite. Inside The Crypto Code Workshop, you’ll get the roadmap to ride this wave — and $10 in free Bitcoin just for showing up.
Pluri Inc. reschedules 2025 annual meeting
See More Headlines

PLUR Stock Analysis - Frequently Asked Questions

Pluri's stock was trading at $4.28 at the beginning of the year. Since then, PLUR stock has increased by 15.7% and is now trading at $4.95.

Pluri Inc. (NASDAQ:PLUR) released its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.94) earnings per share (EPS) for the quarter. The company had revenue of $0.43 million for the quarter. Pluri had a negative trailing twelve-month return on equity of 4,191.91% and a negative net margin of 2,563.29%.

Pluri shares reverse split before market open on Monday, April 1st 2024.The 1-8 reverse split was announced on Monday, April 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, April 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Shares of PLUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pluri investors own include Digital Turbine (APPS), Lightning eMotors (ZEV), Archer Aviation (ACHR), ChargePoint (CHPT) and Canoo (GOEV).

Company Calendar

Last Earnings
5/13/2025
Today
7/18/2025
Next Earnings (Estimated)
9/16/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PLUR
CIK
1158780
Employees
150
Year Founded
N/A

Price Target and Rating

High Price Target
$12.00
Low Price Target
$12.00
Potential Upside/Downside
+144.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($5.53)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.89 million
Net Margins
-2,563.29%
Pretax Margin
-1,789.02%
Return on Equity
-4,191.91%
Return on Assets
-85.40%

Debt

Debt-to-Equity Ratio
51.65
Current Ratio
4.81
Quick Ratio
4.81

Sales & Book Value

Annual Sales
$330 thousand
Price / Sales
117.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.00 per share
Price / Book
4.91

Miscellaneous

Outstanding Shares
7,870,000
Free Float
5,830,000
Market Cap
$38.64 million
Optionable
Optionable
Beta
0.79
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:PLUR) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners